首页> 外文期刊>Journal of the Indian Medical Association. >Medical abortion in late second trimester--a comparative study with misoprostol through vaginal versus oral followed by vaginal route.
【24h】

Medical abortion in late second trimester--a comparative study with misoprostol through vaginal versus oral followed by vaginal route.

机译:中孕晚期的药物流产-比较米索前列醇通过阴道与口服然后阴道途径的对比研究。

获取原文
获取原文并翻译 | 示例
           

摘要

A randomised controlled trial was conducted to compare the relative efficacies of two regimens: Misoprostol given only vaginally or orally followed by vaginal administration of the same drug, for second trimester abortion. Multiparous women with a pregnancy of 16 to 20 weeks with no contra-indications to the drug were selected. They were randomly allocated into two groups. Patients in the first group, the 'only vaginal misoprostol' group (n = 30), were given misoprostol 400 microg 6 hourly only through vaginal route up to a maximum of 4 such doses. Women in the other group, the 'oral plus vaginal misoprostol' group (n = 24), received 400 microg of the drug at intervals of 12 hours for 2 doses, followed by 400 microg 6 hourly per vaginum up to a maximum of 4 such. Ten units of oxytocin was started in all cases when os was 4 cm dilated. Complete expulsion was 83.33% with an average time of 13.28 hours in the only vaginal misoprostol group. Complete expulsion occurred in 87.5% of women receiving oral followed by vaginal misoprostol with an average time of 8.93 +/- 0.01 hours from the first vaginal dose (p<0.05). More importantly, 66.67% women in second group delivered within 10 hours of the vaginal dose. Complete expulsion was defined in those cases where no check curettage was needed. Side-effects were not significant. This implies that misoprostol given by the vaginal route following oral priming doses had a higher success rate and a potential for a reduced hospital stay and higher bed turn-over rate.
机译:进行了一项随机对照试验,比较了两种方案的相对疗效:米索前列醇仅经阴道或口服给予,然后经阴道给予相同药物,用于孕中期流产。选择怀孕16至20周,无禁忌症的多产妇女。他们被随机分为两组。第一组中的患者,“唯一的阴道米索前列醇”组(n = 30),仅通过阴道途径每小时6小时一次给予米索前列醇400微克,最多4剂。另一组妇女,即“口服加阴道米索前列醇”组(n = 24),每隔12小时间隔服用2剂400微克药物,然后每个阴道每小时6次服用400微克,最多4次。在所有情况下,当os扩张4 cm时,开始服用10单位催产素。唯一的阴道米索前列醇组完全驱逐率为83.33%,平均时间为13.28小时。接受口服口服米索前列醇的女性中,有87.5%的女性被完全驱逐,从首次阴道给药开始的平均时间为8.93 +/- 0.01小时(p <0.05)。更重要的是,第二组中有66.67%的妇女在阴道用药后10小时内分娩。在不需要刮除刮宫的情况下定义为完全驱逐。副作用不明显。这意味着口服初剂量后通过阴道途径给予的米索前列醇具有较高的成功率,并且可能减少住院时间和较高的床周转率。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号